Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen

CWH Chan, BMH Law, WKW So, KM Chow… - Journal of cancer …, 2020 - Springer
Purpose To review recent pharmacogenomics studies on breast cancer patients undergoing
tamoxifen therapy, highlighting how our knowledge on cytochrome P450 2D6 (CYP2D6) can …

Ethnic diversity and warfarin pharmacogenomics

IG Asiimwe, M Pirmohamed - Frontiers in pharmacology, 2022 - frontiersin.org
Warfarin has remained the most commonly prescribed vitamin K oral anticoagulant
worldwide since its approval in 1954. Dosing challenges including having a narrow …

Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?

JM Friedman, Y Bombard, B Carleton, AM Issa… - Genetics in …, 2024 - Elsevier
This white paper was prepared by the Global Alliance for Genomics and Health Regulatory
and Ethics Work Stream's Pediatric Task Team to review and provide perspective with …

[HTML][HTML] The role of CYP2C9*2, CYP2C9*3 and VKORC1-1639 variants on the susceptibility of upper gastrointestinal bleeding: A full case-control study

M Forgerini, G Urbano, TR De Nadai… - … of Pharmacy & …, 2023 - frontierspartnerships.org
Purpose: To investigate whether interindividual variability in the CYP2C9 (* 2 and* 3 alleles)
and VKORC1 (rs9923231) genes is associated with increased risk of upper gastrointestinal …

Copy number variation profiling in pharmacogenetics CYP-450 and GST genes in Colombian population

B Ramírez, MJ Niño-Orrego, D Cárdenas… - BMC Medical …, 2019 - Springer
Abstract Background Copy Number variation (CNVs) in genes related to drug absorption,
distribution, metabolism and excretion (ADME) are relevant in the interindividual variability …

Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients

TDC Hirata, C Dagli-Hernandez, FDV Genvigir… - Molecular Diagnosis & …, 2021 - Springer
Anticoagulant and antiplatelet drugs effectively prevent thrombotic events in patients with
cardiovascular diseases, ischemic stroke, peripheral vascular diseases, and other …

Influence of FPGS, ABCC4, SLC29A1, and MTHFR genes on the pharmacogenomics of fluoropyrimidines in patients with gastrointestinal cancer from the Brazilian …

MR Fernandes, JCG Rodrigues, EAF Dobbin… - Cancer Chemotherapy …, 2021 - Springer
Purpose Fluoropyrimidines are one of the most used drug class to treat cancer patients,
although they show high levels of associated toxicity. This study analyzed 33 polymorphisms …

Perception and knowledge of pharmacogenetics among Brazilian psychiatrists

BC Almeida, ED Gonçalves, MH de Sousa… - Psychiatry …, 2021 - Elsevier
Pharmacogenetics (PGx) can optimize drug therapy in psychiatry and is particularly
important in admixed populations. Here we developed and successfully validated a …

Therapeutic drug monitoring in developing nations: assessing the current state of affairs in South America

MV Antunes, R Linden… - Expert opinion on drug …, 2021 - Taylor & Francis
Therapeutic drug monitoring (TDM) aims to offer assistance to clinicians to improve drug
dosing and clinical outcomes, while minimizing the probability of serious adverse effects in …

The prevalence of pharmacogenomics variants and their clinical relevance among the Pakistani population

AR Khan, SH Shah, S Ajaz, S Firasat… - Evolutionary …, 2022 - journals.sagepub.com
Background: Pharmacogenomics (PGx), forming the basis of precision medicine, has
revolutionized traditional medical practice. Currently, drug responses such as drug efficacy …